$BIIB Recent News Why speculators see opportun
Post# of 72711
Posted On: 12/28/2014 11:28:57 AM
$BIIB Recent News
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
Biogen Idec jumps 7%, faring best in S&P 500 9:33 a.m. Dec. 2, 2014 - Victor Reklaitis
Biogen's stock surges on upbeat outlook for Alzheimer's treatment 9:27 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen planning 'aggressively' to start Phase 3 study for Alzheimer's treatment 9:18 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen's stock rallies 5% in premarket trade 8:54 a.m. Dec. 2, 2014 - Tomi Kilgore
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Stock Market News for December 26, 2014 - Market News 10:10 a.m. Dec. 26, 2014 - Zacks.com
After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog 9:25 a.m. Dec. 26, 2014 - Zacks.com
Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog 4:30 p.m. Dec. 24, 2014 - Zacks.com
How Gilead And Johnson & Johnson's Tumble Could've Burned These Hedge Funds 10:27 a.m. Dec. 24, 2014 - benzinga.com
Stock Market News for December 24, 2014 - Market News 10:10 a.m. Dec. 24, 2014 - Zacks.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Dec. 24, 2014 - Zacks.com
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
RBC’s 5 Top Biotech Stocks to Buy for 2015 9:07 a.m. Dec. 23, 2014 - 247WallSt.com
3 Best T. Rowe Price Funds for 2015 5:12 a.m. Dec. 23, 2014 - InvestorPlace.com
Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog 6:10 p.m. Dec. 22, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Express Scripts Picks AbbVie HCV Drugs Over Gilead 4:59 p.m. Dec. 22, 2014 - Investors Business Daily
Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog 4:55 p.m. Dec. 22, 2014 - Zacks.com
Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog 3:20 p.m. Dec. 22, 2014 - Zacks.com
Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog 3:10 p.m. Dec. 22, 2014 - Zacks.com
Eli Lilly-Adocia Strike Deal to Develop Ultra-Rapid Insulin - Analyst Blog 2:50 p.m. Dec. 22, 2014 - Zacks.com
Roche Loses A Little Luster Before Year-End 2:45 p.m. Dec. 22, 2014 - Seeking Alpha
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More 1:37 p.m. Dec. 22, 2014 - TheStreet.com
Puma Biotechnology (PBYI) Jumps: Stock Moves 6.1% Up - Tale of the Tape 9:39 a.m. Dec. 22, 2014 - Zacks.com
Morning Market Losers 9:01 a.m. Dec. 22, 2014 - benzinga.com
Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015 4:01 p.m. Dec. 23, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference 4:01 p.m. Dec. 22, 2014 - BusinessWire - BZX
Alnylam Elects Michael W. Bonney to Its Board of Directors 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Small Cap Profiles: OPXA, NEWC, TRNS, MLER 10:35 a.m. Dec. 11, 2014 - ACCESSWIRE
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Why speculators see opportunity in younger, cyclical stocks 2:50 p.m. Dec. 26, 2014 - The Trading Deck
Cal-Maine Foods shares fall on earnings miss 4:41 p.m. Dec. 23, 2014 - Barbara Kollmeyer
Small caps rise within view of uncharted territory 10:26 a.m. Dec. 22, 2014 - Michael Ashbaugh
S&P 500 back for another crack at major support 10:14 a.m. Dec. 12, 2014 - Michael Ashbaugh
Biogen's Alzheimer's surprise 11:24 a.m. Dec. 9, 2014 - The Trading Deck
U.S. stocks post biggest gain in a month 5:06 p.m. Dec. 2, 2014 - Barbara Kollmeyer
Bob Evans earnings in spotlight after hours 3:41 p.m. Dec. 2, 2014 - Sue Chang
Biogen Alzheimer’s drug skips to Phase 3 testing 3:22 p.m. Dec. 2, 2014 - Russ Britt
Biogen Idec jumps 7%, faring best in S&P 500 9:33 a.m. Dec. 2, 2014 - Victor Reklaitis
Biogen's stock surges on upbeat outlook for Alzheimer's treatment 9:27 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen planning 'aggressively' to start Phase 3 study for Alzheimer's treatment 9:18 a.m. Dec. 2, 2014 - Tomi Kilgore
Biogen's stock rallies 5% in premarket trade 8:54 a.m. Dec. 2, 2014 - Tomi Kilgore
Is the next Cisco out there? 3:23 p.m. Nov. 25, 2014 - The Trading Deck
AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Stock Market News for December 26, 2014 - Market News 10:10 a.m. Dec. 26, 2014 - Zacks.com
After Gilead Sciences, Is it Time to Sell Biotech Stocks? - Analyst Blog 9:25 a.m. Dec. 26, 2014 - Zacks.com
Vanda Gains Fanapt Rights from Novartis for the U.S. Region - Analyst Blog 4:30 p.m. Dec. 24, 2014 - Zacks.com
How Gilead And Johnson & Johnson's Tumble Could've Burned These Hedge Funds 10:27 a.m. Dec. 24, 2014 - benzinga.com
Stock Market News for December 24, 2014 - Market News 10:10 a.m. Dec. 24, 2014 - Zacks.com
Biotech Stock Roundup: AbbVie's HCV Treatment Approved, ImmunoGen Plunges on Data - Analyst Blog 9:48 a.m. Dec. 24, 2014 - Zacks.com
Why I Expect The Biotech Sell-Off To Continue Into 2015 8:08 a.m. Dec. 24, 2014 - Seeking Alpha
RBC’s 5 Top Biotech Stocks to Buy for 2015 9:07 a.m. Dec. 23, 2014 - 247WallSt.com
3 Best T. Rowe Price Funds for 2015 5:12 a.m. Dec. 23, 2014 - InvestorPlace.com
Orexigen's Obesity Drug Mysimba Gets CHMP Nod - Analyst Blog 6:10 p.m. Dec. 22, 2014 - Zacks.com
Genomic Health (GHDX) Shines on Prospective Cancer Tests - Analyst Blog 5:50 p.m. Dec. 22, 2014 - Zacks.com
Express Scripts Picks AbbVie HCV Drugs Over Gilead 4:59 p.m. Dec. 22, 2014 - Investors Business Daily
Roche to Acquire Austrian Biotechnology Company Dutalys - Analyst Blog 4:55 p.m. Dec. 22, 2014 - Zacks.com
Celgene Gets Positive CHMP Recommendation for Revlimid - Analyst Blog 3:20 p.m. Dec. 22, 2014 - Zacks.com
Novo Nordisk's Tresiba Favored by CHMP for Expanded Use - Analyst Blog 3:10 p.m. Dec. 22, 2014 - Zacks.com
Eli Lilly-Adocia Strike Deal to Develop Ultra-Rapid Insulin - Analyst Blog 2:50 p.m. Dec. 22, 2014 - Zacks.com
Roche Loses A Little Luster Before Year-End 2:45 p.m. Dec. 22, 2014 - Seeking Alpha
Jim Cramer Answers Twitter (TWTR) Questions on Gilead, WhiteWave Foods, and More 1:37 p.m. Dec. 22, 2014 - TheStreet.com
Puma Biotechnology (PBYI) Jumps: Stock Moves 6.1% Up - Tale of the Tape 9:39 a.m. Dec. 22, 2014 - Zacks.com
Morning Market Losers 9:01 a.m. Dec. 22, 2014 - benzinga.com
Biogen Idec to Report Fourth Quarter and Year End 2014 Financial Results on January 28, 2015 4:01 p.m. Dec. 23, 2014 - BusinessWire - BZX
Biogen Idec to Present at the 33rd Annual J.P. Morgan Healthcare Conference 4:01 p.m. Dec. 22, 2014 - BusinessWire - BZX
Alnylam Elects Michael W. Bonney to Its Board of Directors 8:02 a.m. Dec. 18, 2014 - BusinessWire - BZX
Biotech Equities Update - Biogen Idec, ACADIA Pharma, Halozyme Therapeutics, Neurocrine Biosciences, and Bluebird Bio 8:50 a.m. Dec. 12, 2014 - PR Newswire - PRF
Small Cap Profiles: OPXA, NEWC, TRNS, MLER 10:35 a.m. Dec. 11, 2014 - ACCESSWIRE
Biogen Idec and Gilead Sciences Join the National Pharmaceutical Council 9:15 a.m. Dec. 9, 2014 - PR Newswire - PRF
Bertilimumab Chosen as a Top Autoimmune/Anti-Inflammatory Projects to Watch 7:30 a.m. Dec. 1, 2014 - PR Newswire - PRF
U.S. Claims Data Show That Biogen Idec's Tecfidera Captured Nearly Half of Second-Line Share Among Newly Diagnosed Multiple Sclerosis Patients 1:30 p.m. Nov. 24, 2014 - PR Newswire - PRF
Sobi exercises opt-in right for Elocta(TM) 2:01 a.m. Nov. 21, 2014 - Thomson Reuters ONE
Vital Therapies Expands Management Team 8:01 a.m. Nov. 20, 2014 - GlobeNewswire
Biogen Idec to Present at the 2014 Deutsche Bank BioFEST Conference 4:01 p.m. Nov. 19, 2014 - BusinessWire - BZX
Forward Pharma Sues Biogen Idec Over Tecfidera(R) Sales in Germany 8:30 a.m. Nov. 18, 2014 - GlobeNewswire
Study Results, Financial Results, Regulatory Updates, and Upcoming Conference - Research Reports on Medtronic, Zoetis, Biogen, Tenet Health and Aetna 8:55 a.m. Nov. 7, 2014 - PR Newswire - PRF
Biogen Idec Foundation to Help NC Science Festival Reach One Million North Carolinians by 2020 10:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
Advance Auto Parts Elects Adriana Karaboutis to Its Board of Directors 8:41 a.m. Nov. 6, 2014 - BusinessWire - BZX
Isis Pharmaceuticals Earns $10 Million Milestone Payment From Biogen Idec for Advancement of ISIS-BIIB3 Rx 7:00 a.m. Nov. 6, 2014 - PR Newswire - PRF
3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Nov. 3, 2014 - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
(0)
(0)Scroll down for more posts ▼